The Annexure

News to 9 October 2026 ·

Desk›Healthcare› Everest Organics Ltd

Everest Organics Ltd

BSE 524790 · NSE EVERESTO · ISIN INE334C01029 · Group X · Active

Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

₹293.05

-0.95%

BSE close, 28 August 2026

Market cap

₹284.57 cr

1.0 cr shares · Micro cap

Free float

₹115.02 cr

as published

P/E · P/B

54.2× · 7.03×

EPS ₹5.41 · BV ₹41.69

FY25-26 rev / PAT

196.16 / 5.55

₹ cr, as filed

Filings, window

16

4 selected · 25%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

52-WK LOW ₹197.00 52-WK HIGH ₹536.40 ₹293.05 28% of range
Against 52-week high-45.4%
Against 52-week low+48.8%
Day change-0.95%
Size bandMicro cap
Index membershipNone

Valuation as published by BSE

Earnings per share₹5.41
Price / earnings54.17×
Price / book7.03×
Book value — derived, price ÷ P/B₹41.69
Return on equity12.98%
Operating margin9.80%
Net margin2.30%

Consistency check

P/B ÷ P/E, which must equal ROE
12.98%
ROE as published
12.98%

Results ₹ crore, as filed

RevenueNet profit one scale across all three periods, ₹ crore

PeriodRevenue ₹cr Net profit ₹cr EPS ₹OPM NPM
Jun-26 · Q 48.43 1.11 1.15 9.80% 2.30%
Mar-26 · Q 48.75 2.63 2.69 14.07% 5.39%
FY25-26 196.16 5.55 5.70 10.74% 2.83%

Quarter on quarter

Revenue, quarter on quarter
-0.7%
Net profit, quarter on quarter
-57.8%
Operating margin, quarter on quarter
-427 bps

Disclosure profile 16 filings in the window

0 median 17.0 p75 · 25 sector max 52 16 47th percentile of 300 Healthcare filers
Shaded is the middle half of the sector, 12 to 25 filings. Measured against the 300 Healthcare companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.
TagFilings
Selected
Change in Directorate2
Board Outcome1
Results1
Selected sub-total4
Procedural
AGM / EGM4
Newspaper Publication2
Annual Report1
Board Meeting1
Book Closure1
Compliance Certificate1
Record Date1
Trading Window1
Procedural sub-total12
Total16

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group X, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Book value is derived as price ÷ P/B; BSE does not publish it directly. Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 93 trading days

16 filings · 4 selected · busiest 2026-08-14

Filing rhythm · the twelve most recent

2026-08-142026-10-08

SelectedProcedural

Filings

16 in the window · 2 earlier on record

  1. 8 October 2026 ·

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Compliance Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 for the Quarter ended September 30, 2026 is enclosed.

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

  2. 30 September 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    Please find enclosed the Scrutinizer Report and Voting Results of 33rd AGM of the Company.

    AGM/EGM / AGM View filing →

  3. 30 September 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Outcome of AGM

    Outcome of the 33rd Annual General Meeting held today i.e. 30th September 2026.

    AGM/EGM / AGM View filing →

  4. 29 September 2026 ·

    Trading Window

    Closure of Trading Window

    Intimation of closure of trading window.

    Insider Trading / SAST / Closure of Trading Window View filing →

  5. 9 September 2026 ·

    Newspaper Publication

    Newspaper Publication

    Newspaper Publication of 33rd AGM and information relating to Remote Evoting

    Company Update / Newspaper Publication View filing →

  6. 8 September 2026 ·

    Annual Report

    Reg. 34 (1) Annual Report.

    33rd Annual Report for the FY 2025-26 is enclosed

    Others / Reg. 34 (1) Annual Report View filing →

  7. 8 September 2026 ·

    AGM / EGM

    Notice Of 33Rd Annual General Meeting And 33Rd Annual Report For The FY 2025-26

    Notice of 33rd Annual General Meeting of the Company along with 33rd Annual Report for the FY 2025-26 is enclosed

    AGM/EGM / AGM View filing →

  8. 17 August 2026 ·

    Newspaper Publication

    Newspaper Publication

    News Paper publications of Un-audited Financial Results for the Quarter ended June 30, 2026

    Company Update / Newspaper Publication View filing →

  9. 14 August 2026 ·

    Record Date

    Fixed The Cut-Off Date For The 33Rd Annual General Meeting Of The Company

    Enclosed

    Corp. Action / Record Date View filing →

  10. 14 August 2026 ·

    Book Closure

    Fixes Book Closure For The 33Rd Annual General Meeting Of The Company

    Enclosed

    Corp. Action / Book Closure View filing →

  11. 14 August 2026 ·

    AGM / EGM

    The 33Rd Annual General Meeting (AGM) Of The Company Scheduled To Be Held On Wednesday, September 30, 2026 At 12.00 Noon (IST) Through Video Conferencing / Other Audio Visual Means (VC/OAVM).

    Enclosed

    AGM/EGM / AGM View filing →

  12. 14 August 2026 ·

    Change in Directorate

    Change in Directorate

    Appointment of Mr. Subroto Banerjee as Additional Director of the Company in the Independent Category w.e.f. August 14, 2026

    Company Update / Change in Directorate View filing →

  13. 14 August 2026 ·

    Change in Directorate

    Change in Directorate

    Appointment of Mr. Srikanth Reddy Kolli as Additional Director in the Independent Category w.e.f. August 14, 2026

    Company Update / Change in Directorate View filing →

  14. 14 August 2026 ·

    Board Outcome

    Board Meeting Outcome for Outcome Of The Board Meeting Held Today

    Enclosed

    Board Meeting / Outcome of Board Meeting View filing →

  15. 14 August 2026 ·

    Results

    Un-Audited Financial Results For The Quarter Ended June 30, 2026

    Enclosed

    Result / Financial Results View filing →

  16. 6 August 2026 ·

    Board Meeting

    Board Meeting Intimation for Meeting Scheduled To Be Held On Friday, August 14, 2026

    Everest Organics Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve Board Meeting is scheduled ....

    Board Meeting / Board Meeting View filing →

RSS feed for Everest Organics Ltd · the 50 most recent filings